DRUG-THERAPY - INHALED GLUCOCORTICOIDS FOR ASTHMA

被引:511
作者
BARNES, PJ
机构
关键词
D O I
10.1056/NEJM199503303321307
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucocorticoids are the most effective therapy available for patients with asthma. They may be administered either orally or, much more safely, by inhalation. With the recognition that airway inflammation is present even in patients with mild asthma, therapy with inhaled glucocorticoids is now recommended at a much earlier stage.1 However, despite their proved efficacy in the treatment of asthma, enthusiasm for their use has been tempered by concern about systemic side effects. Because of this concern, less effective therapies are often preferred, particularly for children. Mechanism of Action Molecular Mechanisms Inhaled glucocorticoids are highly lipophilic. They rapidly enter airway cells,. © 1995, Massachusetts Medical Society. All rights reserved.
引用
收藏
页码:868 / 875
页数:8
相关论文
共 99 条
  • [21] BURKE C, 1992, EUR RESPIR J, V5, P73
  • [22] PURPURA AND DERMAL THINNING ASSOCIATED WITH HIGH-DOSE INHALED CORTICOSTEROIDS
    CAPEWELL, S
    REYNOLDS, S
    SHUTTLEWORTH, D
    EDWARDS, C
    FINLAY, AY
    [J]. BRITISH MEDICAL JOURNAL, 1990, 300 (6739) : 1548 - 1551
  • [23] FLUNISOLIDE METABOLISM AND DYNAMICS OF A METABOLITE
    CHAPLIN, MD
    ROOKS, W
    SWENSON, EW
    COOPER, WC
    NERENBERG, C
    CHU, NI
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (03) : 402 - 413
  • [24] EFFECT OF AN INHALED CORTICOSTEROID ON AIRWAY INFLAMMATION AND SYMPTOMS IN ASTHMA
    DJUKANOVIC, R
    WILSON, JW
    BRITTEN, KM
    WILSON, SJ
    WALLS, AF
    ROCHE, WR
    HOWARTH, PH
    HOLGATE, ST
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (03): : 669 - 674
  • [25] DOMPELING E, 1992, EUR RESPIR J, V5, P945
  • [26] COMPARISON OF 2 HIGH-DOSE CORTICOSTEROID AEROSOL TREATMENTS, BECLOMETHASONE DIPROPIONATE (1500 UG DAY) AND BUDESONIDE (1600 UG DAY), FOR CHRONIC ASTHMA
    EBDEN, P
    JENKINS, A
    HOUSTON, G
    DAVIES, BH
    [J]. THORAX, 1986, 41 (11) : 869 - 874
  • [27] CLINICAL COMPARISON OF INHALED BUDESONIDE DELIVERED EITHER VIA PRESSURIZED METERED DOSE INHALER OR TURBUHALER
    ENGEL, T
    HEINIG, JH
    MALLING, HJ
    SCHARLING, B
    NIKANDER, K
    MADSEN, F
    [J]. ALLERGY, 1989, 44 (03) : 220 - 225
  • [28] RISK OF FATAL AND NEAR-FATAL ASTHMA IN RELATION TO INHALED CORTICOSTEROID USE
    ERNST, P
    SPITZER, WO
    SUISSA, S
    COCKCROFT, D
    HABBICK, B
    HORWITZ, RI
    BOIVIN, JF
    MCNUTT, M
    BUIST, AS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (24): : 3462 - 3464
  • [29] EFFECT OF INHALED CORTICOSTEROIDS ON PERIPHERAL-BLOOD EOSINOPHIL COUNTS AND DENSITY PROFILES IN ASTHMA
    EVANS, PM
    OCONNOR, BJ
    FULLER, RW
    BARNES, PJ
    CHUNG, KF
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (02) : 643 - 650
  • [30] COMPARISON OF FLUTICASONE PROPIONATE WITH BECLOMETHASONE DIPROPIONATE IN MODERATE TO SEVERE ASTHMA TREATED FOR ONE-YEAR
    FABBRI, L
    BURGE, PS
    CROONENBORGH, L
    WARLIES, F
    WEEKE, B
    CIACCIA, A
    PARKER, C
    [J]. THORAX, 1993, 48 (08) : 817 - 823